pharma news

News

Roche gets EU nod for kidney disease algorithm

Roche and Klinrisk have picked up a CE-mark for an AI tool that can be used to predict renal function decline in patients with chronic kidney disease.

News

Delayed TNBC readout for Datroway delivers survival benefit

AstraZeneca and Daiichi Sankyo's Datroway comes good in the delayed TROPION-Breast02 trial as a frontline triple-negative breast cancer treatment.

News

Pills piled together in the shape of the USA

FDA pilots fast-track scheme for US-made generics

In another effort to boost domestic drug manufacturing, the FDA is piloting fast-track reviews for generics tested and made in US facilities.

News

Rocket aborts FDA filing for Fanconi gene therapy

Rocket Pharma has withdrawn a filing in the US for its experimental gene therapy for Fanconi anaemia, but may consider partnering the programme.

News

Cidara gets $339m BARDA award for flu prophylactic

Cidara is celebrating a major injection of funding from the US government for its experimental one-shot, universal flu prophylactic CD388.

News

GLP-1s from Novo, Lilly 'should be first-line in obesity'

European doctors have said GLP-1 drugs are so effective in obesity that they should be the first choice drug treatment in almost all cases.

Roche gets EU nod for kidney disease algorithm

Delayed TNBC readout for Datroway delivers survival benefit

FDA pilots fast-track scheme for US-made generics

Rocket aborts FDA filing for Fanconi gene therapy

Cidara gets $339m BARDA award for flu prophylactic

GLP-1s from Novo, Lilly 'should be first-line in obesity'

Gilead strikes again, penning $5bn deal to buy Tubulis

Using AI-driven synthetic personas to take your insights fur...

pharma news

Editor's Picks